10-Q: Ultralife Q2 Profit Plunges Amid Acquisition Costs

Ultralife Corporation reported a significant decline in second-quarter net income and EPS despite revenue growth driven by its recent Electrochem acquisition, facing increased operating expenses and interest costs.

Summary

• Consolidated revenues for the three-month period ended June 30, 2025, increased 13.0% to $48.56 million, and for the six-month period increased 17.0% to $99.31 million, primarily due to the Electrochem acquisition.
• Net income attributable to Ultralife Corporation for Q2 2025 decreased 70.4% to $0.88 million ($0.05 EPS) from $2.97 million ($0.18 EPS) in Q2 2024.
• Net income for the six-month period ended June 30, 2025, decreased 53.2% to $2.74 million ($0.17 EPS) from $5.86 million ($0.35 EPS) in the prior year period.
• Gross margin declined to 23.9% in Q2 2025 from 26.9% in Q2 2024, and to 24.5% in H1 2025 from 27.1% in H1 2024, due to sales product mix, higher tariffs, freight costs, and lower factory throughput.
• Operating income for Q2 2025 fell 42.5% to $2.26 million, and for H1 2025 fell 29.1% to $5.66 million.
• Operating expenses increased 22.2% in Q2 2025 and 24.2% in H1 2025, driven by the Electrochem inclusion, new product development, and sales/marketing team strengthening.
• Interest and financing expense significantly increased by 137.3% in Q2 2025 and 115.8% in H1 2025 due to the financing of the Electrochem acquisition.
• Cash generated from operations for H1 2025 was $9.30 million, an increase from $8.84 million in H1 2024.
• The company maintains a material weakness in internal control over financial reporting as of June 30, 2025, related to the need for additional accounting personnel.

Sentiment

Score: 3

Explanation: Despite revenue growth driven by the Electrochem acquisition and positive cash flow from operations, the company experienced a substantial decline in net income, EPS, and gross margins. The Communications Systems segment performed poorly, and commercial sales in key areas decreased. The ongoing material weakness in internal controls and significantly higher interest expenses are notable concerns, overshadowing management's optimistic outlook for the second half of the year.

Positives

• Overall consolidated revenue growth of 13.0% in Q2 2025 and 17.0% in H1 2025, primarily driven by the Electrochem acquisition.
• Strong demand from a U.S.-based global prime contractor led to a 61.1% increase in government/defense sales for the Battery & Energy Products segment (excluding Electrochem) in Q2 2025.
• Cash generated from operating activities increased to $9.30 million in H1 2025 from $8.84 million in H1 2024.
• The company was in full compliance with its debt covenants under the New Credit Agreement as of June 30, 2025.
• Management expects improved results in the second half of 2025 and into 2026, citing a rebound in Communications Systems, early purchase orders for battery programs, and sustained growth in global defense spending.
• Successful integration of Electrochem Solutions, Inc., which contributed $9.30 million in revenue and $1.63 million in net income before taxes in Q2 2025.

Negatives

• Significant decline in net income attributable to Ultralife Corporation, down 70.4% in Q2 2025 ($0.88 million) and 53.2% in H1 2025 ($2.74 million).
• Diluted EPS decreased to $0.05 in Q2 2025 from $0.18 in Q2 2024, and to $0.17 in H1 2025 from $0.35 in H1 2024.
• Gross margin declined by 300 basis points in Q2 2025 and 260 basis points in H1 2025, primarily due to unfavorable sales product mix, higher tariff and freight costs, and lower factory throughput.
• Operating income decreased by 42.5% in Q2 2025 and 29.1% in H1 2025.
• Communications Systems segment sales decreased significantly by 57.2% in Q2 2025 and 46.2% in H1 2025 due to prior year shipments and delays in purchase orders.
• Commercial sales (excluding Electrochem) for Battery & Energy Products decreased by 20.4% in Q2 2025, specifically medical sales down 39.0% and oil & gas sales down 23.1%.
• Interest and financing expense more than doubled due to the Electrochem acquisition financing.
• Operating expenses increased significantly, outpacing revenue growth as a percentage of revenue.
• A material weakness in internal control over financial reporting remains un-remediated as of June 30, 2025.

Risks

• Changes in economic conditions including inflation, tariffs, interest rates, and supply chain disruptions adversely affecting business, revenues, and earnings.
• Reliance on certain key customers for a significant portion of revenues.
• Reductions or delays in U.S. and foreign military spending.
• Potential disruptions in raw material and component supply or material cost increases due to business conditions, tariffs, global conflicts, or other factors.
• Resources being overwhelmed by growth.
• Breaches in information systems security and other disruptions in information technology systems.
• Ability to recruit and retain top management and key personnel.
• Unique risks associated with China operations.
• Fluctuations in the price of oil and its impact on demand for downhole drilling.
• Possible future declines in demand for products using batteries or communications systems.
• Safety risks, including fire, inherent in the manufacture, use, and transportation of Lithium batteries.
• Variability in quarterly and annual results and common stock price.
• Rising interest rates increasing the cost of variable borrowings.
• Customers' product quantity purchases not meeting the volume expectations in supply agreements.
• The continued impact of pandemics that may arise, causing delays in the manufacture and delivery of mission-critical products to end customers.
• Potential costs attributable to the warranties supplied with products and services.
• Inability to comply with changes to the regulations for the shipment of products.
• Entrance into new end-markets which could lead to additional financial exposure.
• Negative publicity concerning Lithium-ion batteries.
• Exposure to foreign currency fluctuations.
• Ability to utilize net operating loss carryforwards.
• The risk of being unable to protect proprietary and intellectual property.
• Rules and procedures regarding contracting with the U.S. and foreign governments.
• Possible impairments of goodwill and other intangible assets.
• Ability to comply with government regulations including the use of conflict minerals.
• Exposure to possible violations of the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act or other anti-corruption laws.
• Known and unknown environmental matters.
• Possible audits of contracts by the U.S. and foreign governments and their respective defense agencies.

Future Outlook

Management expects improved results in the second half of 2025 and into 2026, anticipating a rebound in the Communications Systems business, early purchase orders from long-term new product programs for the battery business, a rebound in demand from medical and oil & gas customers, sustained growth in global defense spending, and an expanding opportunity pipeline across both businesses. Priorities include converting long-term new product development efforts into revenue, advancing vertical integration in the oil & gas segment, and maintaining a strong focus on operational efficiency initiatives to deliver sustainable profitable growth and maximize the global brand value.

Management Comments

• Acquiring Electrochem advances our strategy of more fully realizing the operating leverage of our business model through scale and manufacturing cost efficiencies.
• Electrochem brings a blue-chip customer base with little or no overlap with Ultralife's customers, long-tenured technical resources which we plan to utilize in progressing our global new product initiatives, and a complimentary portfolio of highly engineered thionyl, sulfuryl and bromine chloride cells and packs which can be commercially cost prohibitive to substitute or switch out.
• We view this acquisition as an avenue to create highly attractive opportunities to drive revenue growth through heightened cross-selling platforms and extend our reach into underserved adjacent markets that demand uncompromised safety, service, reliability and quality.
• The combination of Electrochem and Ultralife creates achievable opportunities for gross margin expansion through the realization of vertical integration, supply chain synergies and lean initiatives.
• With Electrochem we are increasing our value to our customers and significantly strengthening our competitive position in our end markets.
• Notwithstanding the challenges experienced in the second quarter, we expect improved results in the second half of the year and into 2026.
• We expect our Communications Systems business to rebound from a tough first half, and we are also beginning to see early purchase orders from long-term new product programs for our battery business, a rebound in demand from our medical and oil & gas customers, sustained growth in global defense spending, and an expanding opportunity pipeline across both businesses.
• Our priorities remain converting long-term new product development efforts into revenue, advancing vertical integration in the oil & gas segment, and maintaining a strong focus on operational efficiency initiatives to deliver sustainable profitable growth and maximizing the value of our global brand.

Industry Context

The company's performance reflects mixed industry trends. While the acquisition of Electrochem and strong demand from a U.S.-based global prime contractor boosted Battery & Energy Products revenue, the Communications Systems segment experienced significant declines due to timing delays in purchase orders. Commercial sales in medical and oil & gas sectors also saw declines, indicating sector-specific headwinds. The company's focus on global defense spending aligns with broader industry trends of increased military modernization programs, while challenges in commercial sectors highlight sensitivity to economic and geo-political conditions.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or industry benchmarks to assess the results against global standards. Therefore, a direct comparison is not possible based solely on the provided information.

Management Changes

Corporate Governance

Legal Proceedings

• The company is subject to legal proceedings and claims that arise from time to time in the normal course of business. Management believes that the final disposition of any such matters will not have a material adverse effect on the company's financial position, results of operations, or cash flows. No specific situations are currently known that would have a material adverse impact.

Stakeholder Impact

• Shareholders: Significant decrease in net income and EPS may negatively impact shareholder value and investor confidence. The material weakness in internal controls could also be a concern. However, the potential for future growth from acquisitions and new product programs, along with a potential capital raise, could offer long-term value.
• Employees: The acquisition of Electrochem brings new employees, and the company is hiring additional accounting personnel, indicating job growth in certain areas.
• Customers: The acquisition of Electrochem aims to expand the customer base and offer a complementary product portfolio, potentially enhancing value for customers. Delays in purchase orders for Communications Systems customers could indicate dissatisfaction or market shifts.
• Creditors: The company is in full compliance with its debt covenants, which is positive for creditors. However, increased interest expense reflects higher borrowing costs.
• Suppliers: Higher tariff and freight costs mentioned in the filing could indicate pressure on supply chain relationships or increased costs for suppliers.

Next Steps

• Rebound of Communications Systems business in the second half of 2025.
• Receipt of early purchase orders from long-term new product programs for the battery business.
• Rebound in demand from medical and oil & gas customers.
• Continued sustained growth in global defense spending.
• Converting long-term new product development efforts into revenue.
• Advancing vertical integration in the oil & gas segment.
• Maintaining a strong focus on operational efficiency initiatives.
• Recruiting and hiring additional accounting personnel, including certified public accountants, to remediate the material weakness in internal control over financial reporting.
• Further evaluation and testing of internal controls once corrective actions are fully implemented.
• Potential offering and selling of securities under the new shelf registration statement for general corporate purposes, acquisitions, strategic capital expenditures, and product development.

Key Dates

Recommendation

While Ultralife Corporation achieved revenue growth driven by the Electrochem acquisition and maintained positive operating cash flow, the significant decline in net income, EPS, and gross margins is a major concern. The underperformance of the Communications Systems segment and commercial sales in Battery & Energy Products, coupled with increased interest expenses and an un-remediated material weakness in internal controls, indicate operational challenges. Management's optimistic outlook for H2 2025 and 2026, based on new product programs and defense spending, offers a glimmer of hope, but the current financial performance suggests a 'hold' position until there is clear evidence of improved profitability and successful remediation of internal control issues.

Keywords

Batteries, Energy Products, Communications Systems, Defense, Government Contracts, Lithium Batteries, Power Solutions, SEC Filing, Quarterly Report, Electrochem Acquisition, Financial Results, Manufacturing, Supply Chain, Corporate Governance, Risk Management